ADRB3 adrenergic receptor is a key regulator of human myometrial apoptosis and inflammation during chorioamnionitis

Biology of Reproduction

Volumn 78, Issue 3, 2008, Pages 497-505

  Lirussi, Fréderic ^a   Rakotoniaina, Zo ^a   Madani, Siham ^a   Goirand, Françoise ^a   Breuiller Fouché, Michelle ^b   Leroy, Marie Josèphe ^b   Sagot, Paul ^c   Morrison, John J ^d   Dumas, Monique ^a   Bardou, Marc ^a,e  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b INSERM   (France)

^c HÔPITAL DU BOCAGE   (France)

^d UNIVERSITY HOSPITAL GALWAY   (Ireland)

^e Centre d'Investigation Clinique   (France)

Author keywords

Apoptosis; Bacterial infection; Beta adrenoceptors; Cytokines; Immunology; Inflammation; Lipopolysaccharide; Pregnancy

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; CASPASE 3; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 6; INTERLEUKIN 8; PROTEIN BAX; PROTEIN BCL 2; SAR 150640; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CHORIOAMNIONITIS; CHROMATIN CONDENSATION; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INFLAMMATION; MYOMETRIUM; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR INTRINSIC ACTIVITY; WESTERN BLOTTING;

APOPTOSIS; BENZOATES; CHORIOAMNIONITIS; CYTOKINES; FEMALE; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; MYOMETRIUM; PREGNANCY; PREGNANCY TRIMESTER, THIRD; RECEPTORS, ADRENERGIC, BETA-3; SULFONAMIDES;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 40949159695     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.107.064444     Document Type: Article

References (60)

1. Ananth CV, Joseph KS, Oyelese Y, Demissie K, Vintzileos AM. Trends in preterm birth and perinatal mortality among singletons: United States, 1989 through 2000. Obstet Gynecol 2005; 105:1084-1091.
2. Goldenberg RL, Rouse DJ. Prevention of premature birth. N Engl J Med 1998; 339:313-320.
3. Ananth CV, Misra DP, Demissie K, Smulian JC. Rates of preterm delivery among Black women and White women in the United States over two decades: an age-period-cohort analysis. Am J Epidemiol 2001; 154:657-665.
4. Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Kirmeyer S. Births: final data for 2004. Natl Vital Stat Rep 2006; 55:1-101.
5. Callaghan WM, MacDorman MF, Rasmussen SA, Qin C, Lackritz EM. The contribution of preterm birth to infant mortality rates in the United States. Pediatrics 2006; 118:1566-1573.
6. Edwards RK. Chorioamnionitis and labor. Obstet Gynecol Clin North Am 2005; 32:287-296.
7. Smith R. Parturition. N Engl J Med 2007; 356:271-283.
8. Romero R, Espinoza J, Goncalves LF, Kusanovic JP, Friel LA, Nien JK. Inflammation in preterm and term labour and delivery. Semin Fetal Neonatal Med 2006; 11:317-326.
9. Romero R, Espinoza J, Goncalves LF, Kusanovic JP, Friel L, Hassan S. The role of inflammation and infection in preterm birth. Semin Reprod Med 2007; 25:21-39.
10. Equils O, Lu D, Gatter M, Witkin SS, Bertolotto C, Arditi M, McGregor JA, Simmons CF, Hobel CJ. Chlamydia heat shock protein 60 induces trophoblast apoptosis through TLR4. J Immunol 2006; 177:1257-1263.
11. Haddad R, Tromp G, Kuivaniemi H, Chaiworapongsa T, Kim YM, Mazor M, Romero R. Human spontaneous labor without histologic chorioamnionitis is characterized by an acute inflammation gene expression signature. Am J Obstet Gynecol 2006; 195:394.e1-24.
12. Charpigny G, Leroy MJ, Breuiller-Fouche M, Tanfin Z, Mhaouty-Kodja S, Robin P, Leiber D, Cohen-Tannoudji J, Cabrol D, Barberis C, Germain G. A functional genomic study to identify differential gene expression in the preterm and term human myometrium. Biol Reprod 2003; 68:2289-2296.
13. Havelock JC, Keller P, Muleba N, Mayhew BA, Casey BM, Rainey WE, Word RA. Human myometrial gene expression before and during parturition. Biol Reprod 2005; 72:707-719.
14. Bukowski R, Hankins GD, Saade GR, Anderson GD, Thornton S. Labor-associated gene expression in the human uterine fundus, lower segment, and cervix. PLoS Med 2006; 3:e169.
15. Danial NN, Korsmeyer SJ. Cell death: critical control points. Cell 2004; 116:205-219.
16. Perskvist N, Long M, Stendahl O, Zheng L. Mycobacterium tuberculosis promotes apoptosis in human neutrophils by activating caspase-3 and altering expression of Bax/Bcl-xL via an oxygen-dependent pathway. J Immunol 2002; 168:6358-6365.
17. Morgan RK, Kingham PJ, Walsh MT, Curran DC, Durcan N, McLean WG, Costello RW. Eosinophil adhesion to cholinergic IMR-32 cells protects against induced neuronal apoptosis. J Immunol 2004; 173:5963-5970.
18. Kim A, Shim JY. Emerging tocolytics for maintenance therapy of preterm labour: oxytocin antagonists and calcium channel blockers. Bjog 2006; 113(suppl 3):113-115.
19. Bardou M, Loustalot C, Cortijo J, Simon B, Naline E, Dumas M, Esteve S, Croci T, Chalon P, Frydman R, Sagot P, Manara L, et al. Functional, biochemical and molecular biological evidence for a possible beta(3)-adrenoceptor in human near-term myometrium. Br J Pharmacol 2000; 130:1960-1966.
20. Dennedy MC, Friel AM, Gardeil F, Morrison JJ. Beta-3 versus beta-2 adrenergic agonists and preterm labour: in vitro uterine relaxation effects. Bjog 2001; 108:605-609.
21. Rouget C, Bardou M, Breuiller-Fouche M, Loustalot C, Qi H, Naline E, Croci T, Cabrol D, Advenier C, Leroy MJ. Beta3-adrenoceptor is the predominant beta-adrenoceptor subtype in human myometrium and its expression is up-regulated in pregnancy. J Clin Endocrinol Metab 2005; 90:1644-1650.
22. Rouget C, Breuiller-Fouche M, Mercier FJ, Leroy MJ, Loustalot C, Naline E, Frydman R, Croci T, Morcillo EJ, Advenier C, Bardou M. The human near-term myometrial beta3-adrenoceptor but not the beta2-adrenoceptor is resistant to desensitisation after sustained agonist stimulation. Br J Pharmacol 2004; 141:831-841.
23. Sekut L, Champion BR, Page K, Menius JA Jr, Connolly KM. Anti-inflammatory activity of salmeterol: down-regulation of cytokine production. Clin Exp Immunol 1995; 99:461-466.
24. Bissonnette EY, Befus AD. Anti-inflammatory effect of beta 2-agonists: inhibition of TNF-alpha release from human mast cells. J Allergy Clin Immunol 1997; 100:825-831.
25. Smart KR Jr, Warejcka DJ, Castresana MR, Dalton ML, Webb JG, Newman WH. Isoproterenol inhibits bacterial lipopolysaccharide-stimulated release of tumor necrosis factor-alpha from human heart tissue. Am Surg 2000; 66:947-951.
26. Nishii M, Inomata T, Niwano H, Takehana H, Takeuchi I, Nakano H, Shinagawa H, Naruke T, Koitabashi T, Nakahata J, Izumi T. Beta2-adrenergic agonists suppress rat autoimmune myocarditis: potential role of beta2-adrenergic stimulants as new therapeutic agents for myocarditis. Circulation 2006; 114:936-944.
27. Ito T, Fujimura N, Omote K, Namiki A. A selective beta2-adrenergic agonist, terbutaline, improves sepsis-induced diaphragmatic dysfunction in the rat. Life Sci 2006; 79:905-912.
28. Peebles RS Jr, Permutt S, Togias A. Rapid reversibility of the allergen-induced pulmonary late-phase reaction by an intravenous beta2-agonist. J Appl Physiol 1998; 84:1500-1505.
29. Berkowitz DE, Brown D, Lee KM, Emala C, Palmer D, An Y, Breslow M. Endotoxin-induced alteration in the expression of leptin and beta3-adrenergic receptor in adipose tissue. Am J Physiol 1998; 274:E992-E997.
30. Croci T, Cecchi R, Marini P, Rouget C, Viviani N, Germain G, Guagnini F, Fradin Y, Descamps L, Pascal M, Advenier C, Breuiller-Fouche M, et al. In vitro and in vivo pharmacological characterization of ethyl-4-{trans-4-[((2s)-2- hydroxy-3-{4-hydroxy-3{(methylsulfonyl)amino]-phenoxy}-propyl} amino]cyclohexyl}benzoate hydrochloride (sar150640), a new potent and selective human beta-3-adrenoceptor agonist for the treatment of preterm labor. J Pharmacol Exp Ther 2007; 321:1118-1126.
31. Redline RW, Heller D, Keating S, Kingdom J. Placental diagnostic criteria and clinical correlation-a workshop report. Placenta 2005; 26(suppl A):S114-S117.
32. Redline RW, Faye-Petersen O, Heller D, Qureshi F, Savell V, Vogler C. Amniotic infection syndrome: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol 2003; 6:435-448.
33. Leroy MJ, Cedrin I, Breuiller M, Giovagrandi Y, Ferre F. Correlation between selective inhibition of the cyclic nucleotide phosphodiesterases and the contractile activity in human pregnant myometrium near term. Biochem Pharmacol 1989; 38:9-15.
34. Fortunato SJ, Menon R, Swan KF, Lyden TW. Organ culture of amniochorionic membrane in vitro. Am J Reprod Immunol 1994; 32:184-187.
35. Laemmli UK, Beguin F, Gujer-Kellenberger G. A factor preventing the major head protein of bacteriophage T4 from random aggregation. J Mol Biol 1970; 47:69-85.
36. Sheiner E, Sarid L, Levy A, Seidman DS, Hallak M. Obstetric risk factors and outcome of pregnancies complicated with early postpartum hemorrhage: a population-based study. J Matern Fetal Neonatal Med 2005; 18:149-154.
37. Chanana V, Majumdar S, Rishi P. Involvement of caspase-3, lipid peroxidation and TNF-alpha in causing apoptosis of macrophages by coordinately expressed Salmonella phenotype under stress conditions. Mol Immunol 2007; 44:1562-1569.
38. Zhang XT, Song TB, Du BL, Li DM, Li XM. Caspase-3 antisense oligodeoxynucleotides inhibit apoptosis in gamma-irradiated human leukemia HL-60 cells. Apoptosis 2007; 12:743-751.
39. Muhle RA, Pavlidis P, Grundy WN, Hirsch E. A high-throughput study of gene expression in preterm labor with a subtractive microarray approach. Am J Obstet Gynecol 2001; 185:716-724.
40. Klumpp DJ, Rycyk MT, Chen MC, Thumbikat P, Sengupta S, Schaeffer AJ. Uropathogenic Escherichia coli induces extrinsic and intrinsic cascades to initiate urothelial apoptosis. Infect Immun 2006; 74:5106-5113.
41. Schmitz T, Souil E, Herve R, Nicco C, Batteux F, Germain G, Cabrol D, Evain-Brion D, Leroy MJ, Mehats C. PDE4 inhibition prevents preterm delivery induced by an intrauterine inflammation. J Immunol 2007; 178:1115-1121.
42. Fischer SF, Vier J, Kirschnek S, Klos A, Hess S, Ying S, Hacker G. Chlamydia inhibit host cell apoptosis by degradation of proapoptotic BH3-only proteins. J Exp Med 2004; 200:905-916.
43. Shynlova O, Oldenhof A, Dorogin A, Xu Q, Mu J, Nashman N, Lye SJ. Myometrial apoptosis: activation of the caspase cascade in the pregnant rat myometrium at midgestation. Biol Reprod 2006; 74:839-849.
44. Oger S, Mehats C, Barnette MS, Ferre F, Cabrol D, Leroy MJ. Anti-inflammatory and utero-relaxant effects in human myometrium of new generation phosphodiesterase 4 inhibitors. Biol Reprod 2004; 70:458-464.
45. Chapman NR, Smyrnias I, Anumba DO, Europe-Finner GN, Robson SC. Expression of the GTP-binding protein (Galphas) is repressed by the nuclear factor kappaB RelA subunit in human myometrium. Endocrinology 2005; 146:4994-5002.
46. Dennedy MC, Houlihan DD, McMillan H, Morrison JJ. Beta2- and beta3-adrenoreceptor agonists: human myometrial selectivity and effects on umbilical artery tone. Am J Obstet Gynecol 2002; 187:641-647.
47. Sabbah HN. Biologic rationale for the use of beta-blockers in the treatment of heart failure. Heart Fail Rev 2004; 9:91-97.
48. Fajardo G, Zhao M, Powers J, Bernstein D. Differential cardiotoxic/ cardioprotective effects of beta-adrenergic receptor subtypes in myocytes and fibroblasts in doxorubicin cardiomyopathy. J Mol Cell Cardiol 2006; 40:375-383.
49. Schmitz D, Wilsenack K, Lendemanns S, Schedlowski M, Oberbeck R. Beta-Adrenergic blockade during systemic inflammation: impact on cellular immune functions and survival in a murine model of sepsis. Resuscitation 2007; 72:286-294.
50. Loza MJ, Peters SP, Foster S, Khan IU, Penn RB. Beta-Agonist enhances type 2 T-cell survival and accumulation. J Allergy Clin Immunol 2007; 119:235-244.
51. Lindquist JM, Rehnmark S. Ambient temperature regulation of apoptosis in brown adipose tissue. Erk1/2 promotes norepinephrine-dependent cell survival. J Biol Chem 1998; 273:30147-30156.
52. Kim MJ, Lee JH, Park SY, Hong KW, Kim CD, Kim KY, Lee WS. Protection from apoptotic cell death by cilostazol, phosphodiesterase type III inhibitor, via cAMP-dependent protein kinase activation. Pharmacol Res 2006; 54:261-267.
53. Iwai-Kanai E, Hasegawa K. Intracellular signaling pathways for norepinephrine- and endothelin-1-mediated regulation of myocardial cell apoptosis. Mol Cell Biochem 2004; 259:163-168.
54. Saito S, Kasahara T, Kato Y, Ishihara Y, Ichijo M. Elevation of amniotic fluid interleukin 6 (IL-6), IL-8 and granulocyte colony stimulating factor (G-CSF) in term and preterm parturition. Cytokine 1993; 5:81-88.
55. Figueroa R, Garry D, Elimian A, Patel K, Sehgal PB, Tejani N. Evaluation of amniotic fluid cytokines in preterm labor and intact membranes. J Matern Fetal Neonatal Med 2005; 18:241-247.
56. Tornblom SA, Klimaviciute A, Bystrom B, Chromek M, Brauner A, Ekman-Ordeberg G. Non-infected preterm parturition is related to increased concentrations of IL-6, IL-8 and MCP-1 in human cervix. Reprod Biol Endocrinol 2005; 3:39.
57. Yoon BH, Park CW, Chaiworapongsa T. Intrauterine infection and the development of cerebral palsy. Bjog 2003; 110(suppl 20):124-127.
58. An H, Nishimaki S, Ohyama M, Haruki A, Naruto T, Kobayashi N, Sugai T, Kobayashi Y, Mori M, Seki K, Yokota S. Interleukin-6, interleukin-8, and soluble tumor necrosis factor receptor-I in the cord blood as predictors of chronic lung disease in premature infants. Am J Obstet Gynecol 2004; 191:1649-1654.
59. Shinkai N, Takasuna K, Takayama S. Inhibitory effects of formoterol on lipopolysaccharide-induced premature delivery through modulation of proinflammatory cytokine production in mice. Reproduction 2003; 125:199-203.
60. Nakamura A, Johns EJ, Imaizumi A, Yanagawa Y, Kohsaka T. Effect of beta(2)-adrenoceptor activation and angiotensin II on tumour necrosis factor and interleukin 6 gene transcription in the rat renal resident macrophage cells. Cytokine 1999; 11:759-765.